Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
When levels are low, symptoms such as tiredness, weakness, and reduced concentration can occur
[VERIFY: Confirm current FDA/compounding regulatory status of IGF-1 LR3 with healthcare attorney before publishing
Getting a measurable response at a billionth of a mole is genuinely odd, and that low threshold is still one of the more remarkable things about the peptide
HHS has announced that GHK-Cu is expected to return to Category 1, which would restore the compounding pathway for injectable formulations. BPC-157 On July 23, 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulk Drug Substances List
US$ 21.42
US$ 20.52
US$ 20.25
US$ 20.65
US$ 23.81
US$ 25.94
US$ 25.18
US$ 23.37
